Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

(2-Fluorophenyl)Glycine

    • Product Name (2-Fluorophenyl)Glycine
    • Alias Fmoc-(2-Fluorophenyl)glycine
    • Einecs 629-808-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    336868

    Product Name (2-Fluorophenyl)Glycine
    Cas Number 107294-77-5
    Molecular Formula C8H8FNO2
    Molecular Weight 169.15
    Appearance White to off-white solid
    Melting Point 112-116°C
    Solubility Soluble in water and polar organic solvents
    Purity Typically ≥98%
    Smiles C1=CC=C(C(=C1)F)C(C(=O)O)N
    Inchi InChI=1S/C8H8FNO2/c9-7-4-2-1-3-6(7)5(10)8(11)12/h1-5H,10H2,(H,11,12)
    Synonyms 2-Fluorophenylglycine; α-(2-Fluorophenyl)glycine
    Storage Condition Store at 2-8°C, protected from moisture

    As an accredited (2-Fluorophenyl)Glycine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging is a tightly sealed amber glass bottle containing 25 grams of (2-Fluorophenyl)Glycine, labeled with hazard and chemical information.
    Shipping (2-Fluorophenyl)glycine is shipped in tightly sealed containers, protected from moisture and light, and in compliance with chemical safety regulations. Transport is typically at ambient temperature unless otherwise specified, with clear labeling for handling as a laboratory chemical. Documentation includes safety data and hazard information for safe delivery and storage.
    Storage (2-Fluorophenyl)glycine should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible substances such as strong oxidizers and acids. Store at room temperature and avoid sources of ignition or excessive heat. Proper storage will minimize decomposition and maintain chemical stability.
    Application of (2-Fluorophenyl)Glycine

    Applications of (2-Fluorophenyl)Glycine in Industrial Manufacturing

    As the direct manufacturer of (2-Fluorophenyl)Glycine, we supply this high-purity intermediate to specialized sectors that require precise control over synthesis and formulation. By meeting industry-grade specifications, our product supports complex downstream chemistries across multiple industrial scenarios. Detailed below are practical application segments based on actual market usage, with a focus on process parameters, regulatory frameworks, and finished output.

    1. Pharmaceutical API Intermediate Synthesis

    Pharmaceutical manufacturers utilize (2-Fluorophenyl)Glycine as a key building block in multi-step synthesis routes for several targeted small molecule drug candidates, including fluorinated analogs. Chemical engineers adjust molar ratios during amide coupling or Suzuki reactions, strictly following route-specific protocols. Final compound purification relies on HPLC and mass spectrometry validation to ensure downstream quality. Our audited production process supports large-batch delivery with traceability for clinical and commercial API manufacture.

    Industry compliance standards

    • ICH Q7 GMP Guideline for Active Pharmaceutical Ingredients
    • European Pharmacopoeia for starting materials
    • FDA 21 CFR Part 211 for finished pharmaceuticals
    • China GSP Drug Raw Material Handling Requirements

    Typical usage ratio

    • 0.25–1.5 molar equivalents per API batch, based on lead structure complexity
    • Adjustment based on target molecule synthesis yield and purification recovery

    Downstream process integration

    • Entry as core substrate or protected amino acid fragment in API route
    • Used in initial condensation or amidation steps
    • Monitored during process analytical technology (PAT) checkpoints

    Final product types

    • Active pharmaceutical ingredients (APIs) for CNS, oncology, or anti-infective drug products
    • Registered intermediates under DMF filings
    • Research-grade reference standards for clinical batch validation

    2. Agrochemical Active Ingredient Synthesis

    Agrochemical producers source (2-Fluorophenyl)Glycine as a strategic intermediate when constructing phenylglycine-derived herbicides and insecticides. The fluorine moiety confers selective bioactivity, supporting the development of next-generation crop protection agents. Industrial chemists control concentration and input ratio to minimize by-product formation during condensation and cyclization reactions, maintaining tight contaminant profiles required for downstream formulation and environmental release approvals.

    Industry compliance standards

    • ISO 9001:2015 for raw material traceability
    • OECD Good Laboratory Practice (GLP) for process documentation
    • US EPA Pesticide Registration (40 CFR Part 158)
    • China National Food Safety Standard GB/T 31270.5

    Typical usage ratio

    • 5–12% w/w of starting material charge per batch
    • Titration based on synthesis throughput and target molecule conversion rate

    Downstream process integration

    • Added to reactor as a primary or secondary reactant in heterocyclic ring closure or side-chain modification
    • Intermediate isolated and re-purified before final coupling
    • Quality control at intermediate and final formulating stages

    Final product types

    • Herbicidal actives for cereals and broadleaf crops
    • Insecticidal intermediates in pyrethroid and neonicotinoid synthesis routes
    • Precursors to registered crop protection formulations

    3. Fine Chemical Custom Synthesis

    Contract and custom synthesis companies frequently request (2-Fluorophenyl)Glycine for the development of specialty molecules, particularly in high-performance materials and dye production. Chemists customize reaction scale and reagent ratio, optimizing for yield and selectivity under proprietary conditions. Production batches undergo rigorous in-process controls and final chromatographic purity verification to support applications with stringent end-user specifications.

    Industry compliance standards

    • ISO 9001 and ISO 14001 for management and environmental systems
    • REACH Annex VII–VIII for chemical safety assessment
    • CFR Title 29 OSHA Process Safety Management
    • Internal analytical and QC protocols as specified by downstream clients

    Typical usage ratio

    • 2–15% w/w depending on molecule design and functional group density
    • Adjusted batchwise according to complexity of the target

    Downstream process integration

    • Introduced at aryl condensation or nucleophilic aromatic substitution stages
    • Parallel synthesis setups for high-throughput screening
    • Used in structure–activity relationship (SAR) library construction

    Final product types

    • Functional dyes for industrial textiles and electronics
    • Advanced intermediates for OLED and photoresist manufacturing
    • Specialty chemicals for high-value polymer modification

    4. Peptide and Amino Acid Derivative Manufacturing

    Specialty peptide producers incorporate (2-Fluorophenyl)Glycine into non-natural amino acid libraries for pharma and material science applications. Custom solid-phase or solution-phase synthesis leverages the molecule’s unique structure to alter peptide folding or receptor binding. Ratio and coupling conditions are tightly regulated to prevent racemization and maximize downstream biological activity. Batch records align with quality management systems to ensure dependable lot-to-lot reproducibility.

    Industry compliance standards

    • ISO 13485 for medical and research-grade peptides
    • USP <1047> Peptide Substances – Quality Considerations
    • Synthetic Peptide GMP Guidelines (EMA)
    • IPEC-PQG Good Manufacturing Practices for pharmaceutical excipients

    Typical usage ratio

    • 1 residue per peptide chain (site-specific incorporation)
    • Customized per sequence design in combinatorial libraries

    Downstream process integration

    • Activated as N-protected amino acid during stepwise peptide elongation
    • Participates in fragment condensation under anhydrous conditions
    • QC through LC-MS and NMR on crude and purified product

    Final product types

    • Synthetic peptides for drug discovery screening
    • Fluorinated amino acid reference standards
    • Research reagents for protein–ligand interaction studies

    5. Chiral Building Block in Asymmetric Synthesis

    Producers of chiral catalysts and enantioselective reagents select (2-Fluorophenyl)Glycine as a precursor for manufacturing custom ligands. The chiral center and fluorinated aromatic ring impart selectivity for downstream asymmetric transformations in pharmaceutical and specialty chemical development. Ratio of the starting material is calculated relative to ligand scaffold and monitored throughout catalyst synthesis. Output batches undergo strict chiral purity analysis before shipping for catalytic applications.

    Industry compliance standards

    • ISO 17025 laboratory accreditation for enantiopurity analysis
    • ICH Q11 for drug substance manufacture
    • REACH registration for use as an industrial chemical
    • SHE (safety, health, environmental) protocols for process safety

    Typical usage ratio

    • 0.5–2 equivalents per ligand synthesis batch, varied by target catalyst architecture
    • Fine-tuned according to asymmetric transformation requirements

    Downstream process integration

    • Used in initial condensation or cyclization in ligand preparation
    • Chiral catalysis tested post-synthesis for selectivity benchmarks
    • Enantiomeric excess confirmed by HPLC or chiral GC

    Final product types

    • Chiral ligands for metal-catalyzed asymmetric synthesis
    • Enantioselective catalysts for commercial process development
    • Reference materials for enantioselectivity screening
    Free Quote

    Competitive (2-Fluorophenyl)Glycine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    (2-Fluorophenyl)Glycine: Specialty Amino Acid for Advancing Synthesis

    Dedicated Development for Pharmaceutical Research

    Our team at the plant handles a steady demand for (2-Fluorophenyl)glycine. Over the years, we have observed the shift in medicinal chemistry toward the design of small molecules that maximize specificity and absorption. The addition of a fluorine atom to the aromatic ring of glycine increases metabolic stability and alters the molecule’s polarity. Rather than just supplying another glycine derivative, we have refined the production of this compound to give consistent, high-purity material.

    Each lot of (2-Fluorophenyl)glycine leaves our facility with the clean, crystalline appearance we expect from a controlled synthesis. Seasoned bench chemists actively monitor the reactors, not only relying on instrumentation but also using years of accumulated hands-on experience. Handling of intermediates, crystallization steps, and final drying all receive critical attention during every batch. This care translates into a final amino acid with minimal impurities, meeting the tight specifications required in discovery labs and pilot projects.

    Comparison to Standard Glycine and Other Aromatic Amino Acids

    In contrast to simple glycine, (2-Fluorophenyl)glycine’s aromatic character unlocks new options for peptide design and medicinal modification. Our own product development teams have watched its use spread from core peptide intermediates into enzyme inhibitor design, catalyst ligands, and as a chiral auxiliary in asymmetric synthesis. A standard glycine or phenylglycine does not offer this specific balance of lipophilicity and electronic influence that the ortho-fluorine imparts.

    There is a reason why synthetic chemists request this building block for specific SAR explorations. Fluorination at the ortho position means that the phenyl ring no longer mimics simple phenylalanine or classic benzyl side chains. Instead, the electron-withdrawing effect helps to modulate hydrogen bonding and solubility within a molecule, which we have seen create downstream effects on compound behavior in biological assays. We have witnessed local researchers modify lead candidates by swapping in this amino acid and secure improved binding to protein targets, reflecting the subtle but valuable impact of the fluorine atom.

    Our Manufacturing Approach and Insights

    Many manufacturers treat specialty building blocks as commodity intermediates, relying on unmonitored, uncontrolled conditions. Our process design sits on the shoulders of chemists who built up knowledge across decades. We favor batchwise monitoring and incremental optimization. For (2-Fluorophenyl)glycine, this includes multi-stage purification and specific reactor profiles that maintain the integrity of the sensitive fluorinated ring.

    Scaling up this type of aromatic amino acid presents unique challenges compared to simpler glycine derivatives. The ortho-fluorine affects both reactivity and the way the molecule crystallizes. Some contract manufacturers have failed to achieve reproducibility or scale, but our in-house synthesis and purification lines allow adjustments to mixing, temperature profile, and solvent recovery in real time. Operating with direct communication between process engineers and analytical chemists, we catch impurities or unwanted byproducts early, long before they reach later stages.

    From direct observations, we know residual solvents or side-chain isomers can easily evade instruments if the operator only chases throughput. Daily experience has shown the importance of sight, smell, and texture for intermediary slurries. These “soft signals” supplement the more formal HPLC and NMR checks. Our team’s fingerprint on each batch appears most strongly in the repeatability and homogeneity of the final powder.

    Consistent Specifications and Laboratory Value

    In research and pilot applications, chemists need more than just theoretical purity; they require real, dependable performance. One batch with traces of regioisomers or residual fluorinated byproducts can disrupt a peptide synthesis or bioassay, leading to lost weeks in project timelines. Early customers relied on our transparency around analytical results and our commitment to lot-to-lot consistency. We learned that research projects collapse not from visible errors, but from unseen inconsistencies in raw materials.

    (2-Fluorophenyl)glycine features in demanding fields, including targeted drug design and advanced materials. With each cycle, our technical teams adjust for seasonal shifts in humidity, temperature, and even local electricity supply—minor factors that, over years, affect batch repeatability. Our experience reveals that the most sensitive applications unmask even tiny process variations. For example, oligopeptide synthesizers penalize materials with high moisture content or with micro-level spectral outliers, turning a pure-looking powder into an unusable lot. By controlling every step from precursor handling through to packaging, we maintain a level of confidence that partners count on when testing unproven lead compounds.

    Addressing Real-World Challenges in Production

    Working as a chemical manufacturer involves day-to-day problem solving, not theoretical exercise. During the scale-up of (2-Fluorophenyl)glycine, we faced recurrent foaming problems at one precipitation step, where released gases would carry product into the exhaust. Years of experimentation led to a redesign of agitation equipment and the introduction of controlled anti-foam additions, minimizing both loss and batch-to-batch inconsistency.

    Another significant improvement stemmed from better control of acid-base cycles during isolation. Early processes yielded more colored material, with minute levels of decomposed aromatic fragments. Through targeted pH adjustments and crystallization temperature shifts, our operators restored purity, guided as much by observation as by analysis.

    Whereas other vendors might accept a “mostly pure” assay, our standards are higher. Every gram of (2-Fluorophenyl)glycine must reflect hands-on craftsmanship. Each process change draws on root cause analysis and lessons from previous plant campaigns. Sharing these stories with industry peers has built our reputation for reliability in specialty amino acid supply.

    Supporting Customers in Applications Beyond Synthesis

    We field requests for technical support that extend far beyond basic ordering. Researchers approach us with questions about reactivity profiles, solubility, and compatibility in SPPS workflows. Over time, we have compiled a growing set of case studies where (2-Fluorophenyl)glycine contributed to project success. Teams focused on fluorinated peptide probes, click-chemistry linkers, or new small-molecule inhibitors have provided feedback on downstream performance.

    Practical feedback directly informs product improvements. For example, one customer documented minor rate reductions during automated peptide chain elongation when using lower-grade material from another source. Upon switching to our flagship grade, their workflow returned to expected cycle times. We ran mirror syntheses in our applications lab to confirm these findings and now incorporate advanced drying methods to lower residual water levels, maximizing coupling efficiency.

    Because (2-Fluorophenyl)glycine rarely functions as the only building block in an experiment, its ability to blend into complex mixtures without introducing variables remains essential. This product attracts synthetic chemists not for its novelty but for its dependability in experimental sequences that leave little margin for error. Based on years of hands-on troubleshooting, we advise customers on dissolution procedures and pre-activation steps to prevent clumping or incomplete reactions, which can occur given the unique hydrogen bonding profile introduced by the ortho-fluorine.

    Safety and Sustainability in Practice

    Handling fluorinated intermediates calls for disciplined attention to safety protocols, especially during the earliest stages of synthesis. We have invested substantially in process containment infrastructure, advanced scrubbers, and continuous air monitoring. Our in-house training prioritizes not only compliance, but true understanding of exposure routes for each intermediate. By continually evaluating waste streams during purification, we seek to minimize the environmental footprint of our plant.

    Crucially, our approach balances safety with resource efficiency. Recovered solvents are returned to larger plant streams where possible, with targeted analysis to prevent cross-contamination. Over time, this waste minimization model reduces both environmental load and input costs, without sacrificing product quality. We do not tout perfection, but real progress measured by the weight of safe, accountable output at the end of every campaign.

    Why We Prioritize Analytical Rigor and Technical Transparency

    Our plant’s legacy is grounded in a culture of scientific rigor, not salesmanship. We invite partners and visiting scientists to tour our control room and see results firsthand. With (2-Fluorophenyl)glycine, every batch receives full NMR, HPLC, and mass spectrometry analysis, and we release full spectra to users who want to integrate raw data into their own compliance files.

    We make no assumptions that internal protocols elsewhere duplicate ours. Several long-term collaborations grew out of labs that struggled to reproduce published findings using third-party material, only resolving discrepancies once they sourced from us directly. This experience solidified our belief that direct communication between supplier and researcher slows project attrition and speeds up innovation cycles. We value this trust as much as the technical transactions themselves.

    Continuous Learning from Industry Partnerships

    We strengthen our offering through systematic feedback and industry partnership. Academic and pharmaceutical clients provide the real-world insight that helps us improve both process and product. For instance, a leading discovery group found that their standard coupling additives produced lower yields with the ortho-fluorinated glycine, prompting us to test alternate solvents, which ultimately provided a better route to high-yielding products for everyone involved.

    Our technical staff regularly participates in external symposia and internal cross-trainings to ensure that state-of-the-art knowledge flows back into production. Instead of simply reacting to problems, we preempt common pitfalls by updating procedures in anticipation of the evolving needs of our customers. This attitude, reinforced by concrete results, allows us to remain a preferred partner for increasingly complex molecular projects.

    We document and adapt to every unique usage scenario shared by customers, refining our recommendations based on these lived experiences. This system equips new researchers with practical tips gleaned from the field, saving time and reducing experimental dead ends. Efficient troubleshooting—rooted in both craft and technical evidence—keeps projects on track.

    Future Directions and Commitment to Reliable Supply

    As specialty amino acids like (2-Fluorophenyl)glycine gain traction in emerging fields such as radiopharmaceuticals and advanced diagnostics, the requirements for purity, traceability, and delivery continue to tighten. Our ongoing investments in in-house analytics, cross-departmental QA programs, and technical cross-training ensure that we stay ahead of these rising expectations.

    Looking ahead, we plan to expand capacity while maintaining a focus on batch reproducibility. We are developing automated monitoring protocols and additional purification steps, learning directly from production setbacks and customer feedback. Our team’s approach is never static. We remain open to process improvements and outside critiques—in fact, these are essential to refining every aspect of what we deliver.

    (2-Fluorophenyl)glycine stands as both a technical achievement and a practical resource for pioneers in pharmaceutical and chemical research. We maintain this standard only through rigorous attention, direct engagement with users, and the accumulated wisdom of our entire production staff. Each kilogram produced carries the pride and diligence of our crew. We invite you to challenge our product with your next innovation, knowing that real progress in the lab depends on trusted collaborators at every stage.